Inhibition of Delayed Cerebral Ischemia by Magnesium Is Insufficient for Subarachnoid Hemorrhage Patients: A Network Meta-Analysis.
Xiao-Hong BaXiao-Di WangYong-Yi DaiPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
This study supports the beneficial effect of magnesium in reducing the risk of delayed cerebral ischemia. Based on a single randomized controlled trial, immediate intracranial magnesium therapy with intravenous hydrogen after subarachnoid hemorrhage can increase the good recovery rate. Therefore, more high-quality studies are needed to confirm this finding.
Keyphrases
- subarachnoid hemorrhage
- cerebral ischemia
- brain injury
- randomized controlled trial
- end stage renal disease
- blood brain barrier
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- high dose
- stem cells
- study protocol
- systematic review
- mesenchymal stem cells
- patient reported
- optical coherence tomography